Sponsors

Ready-to-use miRNA assays

Two ready-to-use microRNA (miRNA) assay technologies have been introduced by Qiagen. The two new products, miScript miRNA Mimics and miScript miRNA Inhibitors, are ready-totransfect items for use in gene regulation and cellular pathway analysis.

miScript miRNA Mimics are synthetic RNA oligonucleotides that function like mature endogenous miRNA molecules when transfected in mammalian cells. miScript miRNA Inhibitors are synthetic chemically modified RNA oligonucleotides that inhibit endogenously expressed miRNAs. miRNA Inhibitors effectively lower the levels of endogenous miRNA in cells, thus enabling loss-of-function studies to be performed.

Qiagen supplies miScript miRNA Mimics and miScript miRNA Inhibitors in formats from single tubes to 96- or 384-well plates, and also in different scales (1 nmol and 5 nmol for in vitro use, and 20 nmol for animal studies).

www.qiagen.com

Latest Issues

11th Digital Pathology & AI Congress: Europe

Hilton London Metropole, 255 Edgware Road, London, W2 1JU
11-12 December, 2024

Microbiology Society Annual Conference 2025

Liverpool Arena and Convention Centre
31 March - 3 April, 2025

BSMT Annual Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025

Ghent Pathology 2025

ICC Ghent, Belgium
24-26 June, 2025

37th European Congress of Pathology

ACV, Vienna, Austria
6 -10 September, 2025